Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Haemonetics (NYSE: HAE) announced that its fourth quarter fiscal 2026 results for the period ended March 28, 2026 are posted on the company Investor Relations website.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics (NYSE: HAE) announced that its fourth quarter fiscal 2026 results for the period ended March 28, 2026 are posted on the company Investor Relations website. The company will host a live conference call and webcast on May 7, 2026 at 8:00 a.m. ET.
Replay of the call will be available beginning at 11:00 a.m. ET on May 7, 2026 and remain accessible for one year. Earnings release and supplemental presentation are posted and will be referenced during the call.
Details
News Market Reaction – HAE
On May 7, the day this news came out, HAE closed 3.23% above the previous close.
Data tracked by StockTitan Argus for the May 7 session.
Key Figures
- Quarter end date
- March 28, 2026
- Fourth quarter fiscal year 2026 period end
- Current share price
- $52.67
- Pre-news market context for HAE
- Daily price change
- -5.3%
- 24-hour move prior to earnings posting
- Relative volume
- 1.84x
- Today vs 20-day average volume
- 52-week high
- $87.32
- Pre-news 52-week range high for HAE
- 52-week low
- $47.315
- Pre-news 52-week range low for HAE
- Conference call time
- 8:00 a.m. ET
- Scheduled on May 7, 2026 to discuss Q4 FY26 results
- Replay availability
- 1 year
- Conference call and webcast replay from 11:00 a.m. ET May 7, 2026
Previous Earnings Reports
-
Third quarter fiscal 2026 results and call details posted online.
-
Second quarter fiscal 2026 results and related materials released.
-
First quarter fiscal 2026 results made available with webcast.
-
Fourth quarter and fiscal 2025 financial results and guidance posted.
-
Third quarter fiscal 2025 earnings release and webcast information.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Financial release and supplemental presentation accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 7, 2026.
Conference Call and Webcast Information:
- Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
- Live webcast: Access here or through the Investor Relations section of the Haemonetics website.
A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on May 7, 2026 and will remain accessible for one year via the webcast link above.
Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:
- Fourth Quarter Fiscal 2026 Earnings Release
- Fourth Quarter Fiscal 2026 Supplemental Earnings Presentation
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com
David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-fourth-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302764893.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.